Literature DB >> 16626406

Serodiagnostic comparison between two methods, ELISA and surface plasmon resonance for the detection of antibody titres of Mycoplasma hyopneumoniae.

T J Kim1, H S Cho, N Y Park, J I Lee.   

Abstract

A protein chip based on surface plasmon resonance (SPR) was developed for measuring the Mycoplasma hyopneumoniae antibody titres using a recombinant 30-kDa fragment of P97 adhesin as an antigen. The diagnostic potential of this SPR assay, for detecting the antibody titres to the M. hyopneumoniae 30-kDa protein, was compared with that of conventional ELISA using 70 pig serum samples taken from six pig farms. The SPR assay was found to be highly specific and sensitive. Moreover, there was a strong positive correlation between the SPR and ELISA titres (n = 70, r = 0.898, P < 0.01). Therefore, this recombinant 30-kDa protein can be used as an antigen for serological studies, and the SPR, which is a label-free method, is expected to be a valuable and reproducible tool in the serodiagnosis of M. hyopneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626406     DOI: 10.1111/j.1439-0450.2006.00917.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  3 in total

1.  Rapid serodiagnosis with the use of surface plasmon resonance imaging for the detection of antibodies against major surface protein A of Mycoplasma synoviae in chickens.

Authors:  Kiseok Oh; Semi Lee; Jayoung Seo; Dongwoo Lee; Taejung Kim
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

Review 2.  Laboratory Diagnosis of Paratyphoid Fever: Opportunity of Surface Plasmon Resonance.

Authors:  Dina M Alhaj-Qasem; Mohammad A I Al-Hatamleh; Ahmad Adebayo Irekeola; Muhammad Fazli Khalid; Rohimah Mohamud; Aziah Ismail; Fatin Hamimi Mustafa
Journal:  Diagnostics (Basel)       Date:  2020-06-28

Review 3.  Current issues on molecular and immunological diagnosis of tuberculosis.

Authors:  Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.